Before visiting, please review our current visitor policies and COVID-19 information.

Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Clinical Trials Search

As a clinical trial candidate at Methodist, you’re offered unique access to new drugs and technology being studied to improve patient outcomes.
Filter by Disease or Condition
Showing 1-10 results of 19
Lung Cancer

Alliance A081801

Official Title: Testing The Addition Of A Type Of Drug Called Immunotherapy To The Usual Chemotherapy Treatment For Non-Small Cell Lung Cancer
Study Purpose: To compare the usual treatment alone to using pembrolizumab plus the usual treatment.  The addition of pembrolizumab to the usual treatment could prevent it from returning.
Status: Suspended
Lung Cancer

Alliance A151216

Official Title: Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Study Purpose: To study the genes of tumor cells to determine if these results will help physicians select the best treatment options for patients with genetic changes. 
Status: Recruiting
Lung Cancer

Alliance A171901

Official Title: Testing the effects of mk-3475 (pembrolizumab) with or without the usual chemotherapy treatment for patients 70 years of age and older with advanced non-small cell lung cancer.
Study Purpose: To find out if patients aged 70 years or older have different side effects than younger patients from treatment with the usual approach for non-small cell lung cancer.
Status: Recruiting
Lung Cancer

AstraZeneca D4194C00008

Official Title: Prospective, Interventional Pilot Study Of Mobile Devices And Digital Applications To Detect Early Pneumonitis And Other Pulmonary Adverse Events In Unresectable Stage Iii Non-Small Cell Lung Cancer Patients On Durvalumab
Study Purpose: To test new technology that monitors your respiratory function data, oxygen saturation levels, vital signs, and physical movement data without affecting your daily life in a significant way.
Status: Recruiting
Lung Cancer

Biodesix, Inc. BDX-00146

Official Title: An observational study assessing the clinical effectiveness of the VeriStrat test and validation immunotherapy tests in subjects with non-small cell lung cancer
Study Purpose: To collect information about how the study doctor uses the results of the VeriStrat blood test to choose treatment for NSCLC.
Status: Recruiting
Lung Cancer

CTSU E4512

Official Title: A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Study Purpose: To compare any good and bad effects of using the study drug, crizotinib, after completion of surgery and, in some cases, after chemotherapy and/or radiation therapy for ALK-positive non-small cell lung cancer.
Status: Recruiting
Lung Cancer

CTSU LungMap

Official Title: Targeted Treatment for Advanced Non-small Cell Lung Cancer
Study Purpose: To find out if a targeted or immunotherapy treatment will have an effect on specific genes and proteins in the tumor.
Status: Recruiting
Lung Cancer

CTSU S1827

Official Title: Testing Whether the Of Brain Scans Alone Instead Of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients with Small Cell Lung Cancer
Study Purpose: To see if the use of brain scans alone instead of brain scans plus preventive brain radiation affect the lifespan of patients with small cell lung cancer.
Status: Recruiting
Lung Cancer

ECOG-ACRIN EA5162

Official Title: Phase II Study of Osimertinib in Advanced NSCLC Patients with Exon 20 Mutations in EGFR
Study Purpose: To evaluate the best objective response rate of AZD9291 (osimertinib) among patients with EGFR exon 20 insertions.
Status: Suspended
Lung Cancer

ECOG-ACRIN EA5163

Official Title: A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature-Driven Analysis
Study Purpose: To find out whether either of these two usual approaches to treating this type of cancer is better or worse than the other.
Status: Recruiting